Research Database

162 studies found

Positive

120

74.1%

Negative

6.8%

Inconclusive

17.3%

Page 6 of 9

PositiveAnimal Study - Veterinary Clinical Trial

Association between cannabis use and complications related to ulcerative colitis in hospitalized patients

2019

IBD - Crohn's DiseaseIBD - Inflammatory Bowel DiseaseIBD - Ulcerative Colitis+1

InconclusiveReview/Other

Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

2019

Crohn's Disease

PositiveReview/Other

Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer

2019

Cancer - Colon

InconclusiveReview/Other

The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.

2018

IBD - Crohn's Disease

PositiveAnimal Study -

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

2018

Inflammation

InconclusiveReview/Other

Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.

2018

IBD - Inflammatory Bowel Disease

PositiveReview/Other

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

2018

Multiple Sclerosis

PositiveReview/Other

Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis

2018

Cancer

PositiveReview/Other

Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation.

2018

IBD - Inflammatory Bowel Disease

PositiveMeta-analysis -

The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

2018

IBD - Inflammatory Bowel Disease

PositiveReview/Other

Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.

2017

IBD - Inflammatory Bowel Disease

PositiveReview/Other

Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

2017

IBD - Inflammatory Bowel Disease

PositiveReview/Other

The impact of exertional-heat stress on gastrointestinal integrity, gastrointestinal symptoms, systemic endotoxin and cytokine profile

2017

IBD - Inflammatory Bowel Disease

PositiveAnimal Study -

Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease

2017

IBD - Crohn's Disease

InconclusiveDouble Blind Clinical Trial

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial

2017

IBD - Crohn's Disease

PositiveReview/Other

Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.

2017

IBD - Crohn's Disease

PositiveReview/Other

(+)-Borneol Improves the Efficacy of Edaravone Against DSS-induced Colitis by Promoting M2 Macrophages Polarization via JAK2-STAT3 Signaling Pathway

2017

IBD - Inflammatory Bowel Disease

Command Palette

Research Database

Association between cannabis use and complications related to ulcerative colitis in hospitalized patients

Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews

Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer

Cannabis for the treatment of ulcerative colitis

Cannabis for the treatment of Crohn's disease

Cannabis and pediatric inflammatory bowel disease: change blossoms a mile high.

The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn's and Colitis Foundation.

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis

Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation.

The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.

Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.

The impact of exertional-heat stress on gastrointestinal integrity, gastrointestinal symptoms, systemic endotoxin and cytokine profile

Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial

Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.

(+)-Borneol Improves the Efficacy of Edaravone Against DSS-induced Colitis by Promoting M2 Macrophages Polarization via JAK2-STAT3 Signaling Pathway